Global Antimicrobial Peptides Market Insights And Forecast To 2028

1 Study Coverage
1.1 Antimicrobial Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Antimicrobial Peptides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Market by Application
1.3.1 Global Antimicrobial Peptides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antimicrobial Peptides Sales Estimates and Forecasts 2017-2028
2.2 Global Antimicrobial Peptides Revenue Estimates and Forecasts 2017-2028
2.3 Global Antimicrobial Peptides Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antimicrobial Peptides Sales by Region
2.4.1 Global Antimicrobial Peptides Sales by Region (2017-2022)
2.4.2 Global Sales Antimicrobial Peptides by Region (2023-2028)
2.5 Global Antimicrobial Peptides Revenue by Region
2.5.1 Global Antimicrobial Peptides Revenue by Region (2017-2022)
2.5.2 Global Antimicrobial Peptides Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antimicrobial Peptides Sales by Manufacturers
3.1.1 Global Top Antimicrobial Peptides Manufacturers by Sales (2017-2022)
3.1.2 Global Antimicrobial Peptides Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antimicrobial Peptides in 2021
3.2 Global Antimicrobial Peptides Revenue by Manufacturers
3.2.1 Global Antimicrobial Peptides Revenue by Manufacturers (2017-2022)
3.2.2 Global Antimicrobial Peptides Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Revenue in 2021
3.3 Global Antimicrobial Peptides Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antimicrobial Peptides Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antimicrobial Peptides Sales by Type
4.1.1 Global Antimicrobial Peptides Historical Sales by Type (2017-2022)
4.1.2 Global Antimicrobial Peptides Forecasted Sales by Type (2023-2028)
4.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2017-2028)
4.2 Global Antimicrobial Peptides Revenue by Type
4.2.1 Global Antimicrobial Peptides Historical Revenue by Type (2017-2022)
4.2.2 Global Antimicrobial Peptides Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
4.3 Global Antimicrobial Peptides Price by Type
4.3.1 Global Antimicrobial Peptides Price by Type (2017-2022)
4.3.2 Global Antimicrobial Peptides Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antimicrobial Peptides Sales by Application
5.1.1 Global Antimicrobial Peptides Historical Sales by Application (2017-2022)
5.1.2 Global Antimicrobial Peptides Forecasted Sales by Application (2023-2028)
5.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2017-2028)
5.2 Global Antimicrobial Peptides Revenue by Application
5.2.1 Global Antimicrobial Peptides Historical Revenue by Application (2017-2022)
5.2.2 Global Antimicrobial Peptides Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
5.3 Global Antimicrobial Peptides Price by Application
5.3.1 Global Antimicrobial Peptides Price by Application (2017-2022)
5.3.2 Global Antimicrobial Peptides Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antimicrobial Peptides Market Size by Type
6.1.1 North America Antimicrobial Peptides Sales by Type (2017-2028)
6.1.2 North America Antimicrobial Peptides Revenue by Type (2017-2028)
6.2 North America Antimicrobial Peptides Market Size by Application
6.2.1 North America Antimicrobial Peptides Sales by Application (2017-2028)
6.2.2 North America Antimicrobial Peptides Revenue by Application (2017-2028)
6.3 North America Antimicrobial Peptides Market Size by Country
6.3.1 North America Antimicrobial Peptides Sales by Country (2017-2028)
6.3.2 North America Antimicrobial Peptides Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antimicrobial Peptides Market Size by Type
7.1.1 Europe Antimicrobial Peptides Sales by Type (2017-2028)
7.1.2 Europe Antimicrobial Peptides Revenue by Type (2017-2028)
7.2 Europe Antimicrobial Peptides Market Size by Application
7.2.1 Europe Antimicrobial Peptides Sales by Application (2017-2028)
7.2.2 Europe Antimicrobial Peptides Revenue by Application (2017-2028)
7.3 Europe Antimicrobial Peptides Market Size by Country
7.3.1 Europe Antimicrobial Peptides Sales by Country (2017-2028)
7.3.2 Europe Antimicrobial Peptides Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antimicrobial Peptides Market Size by Type
8.1.1 Asia Pacific Antimicrobial Peptides Sales by Type (2017-2028)
8.1.2 Asia Pacific Antimicrobial Peptides Revenue by Type (2017-2028)
8.2 Asia Pacific Antimicrobial Peptides Market Size by Application
8.2.1 Asia Pacific Antimicrobial Peptides Sales by Application (2017-2028)
8.2.2 Asia Pacific Antimicrobial Peptides Revenue by Application (2017-2028)
8.3 Asia Pacific Antimicrobial Peptides Market Size by Region
8.3.1 Asia Pacific Antimicrobial Peptides Sales by Region (2017-2028)
8.3.2 Asia Pacific Antimicrobial Peptides Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antimicrobial Peptides Market Size by Type
9.1.1 Latin America Antimicrobial Peptides Sales by Type (2017-2028)
9.1.2 Latin America Antimicrobial Peptides Revenue by Type (2017-2028)
9.2 Latin America Antimicrobial Peptides Market Size by Application
9.2.1 Latin America Antimicrobial Peptides Sales by Application (2017-2028)
9.2.2 Latin America Antimicrobial Peptides Revenue by Application (2017-2028)
9.3 Latin America Antimicrobial Peptides Market Size by Country
9.3.1 Latin America Antimicrobial Peptides Sales by Country (2017-2028)
9.3.2 Latin America Antimicrobial Peptides Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antimicrobial Peptides Market Size by Type
10.1.1 Middle East and Africa Antimicrobial Peptides Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antimicrobial Peptides Revenue by Type (2017-2028)
10.2 Middle East and Africa Antimicrobial Peptides Market Size by Application
10.2.1 Middle East and Africa Antimicrobial Peptides Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antimicrobial Peptides Revenue by Application (2017-2028)
10.3 Middle East and Africa Antimicrobial Peptides Market Size by Country
10.3.1 Middle East and Africa Antimicrobial Peptides Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antimicrobial Peptides Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AnaSpec
11.1.1 AnaSpec Corporation Information
11.1.2 AnaSpec Overview
11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AnaSpec Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AnaSpec Recent Developments
11.2 AMP Biotech
11.2.1 AMP Biotech Corporation Information
11.2.2 AMP Biotech Overview
11.2.3 AMP Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AMP Biotech Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AMP Biotech Recent Developments
11.3 Phoenix Biotech
11.3.1 Phoenix Biotech Corporation Information
11.3.2 Phoenix Biotech Overview
11.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Phoenix Biotech Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Phoenix Biotech Recent Developments
11.4 Novabiotics
11.4.1 Novabiotics Corporation Information
11.4.2 Novabiotics Overview
11.4.3 Novabiotics Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novabiotics Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novabiotics Recent Developments
11.5 Chinese Peptide
11.5.1 Chinese Peptide Corporation Information
11.5.2 Chinese Peptide Overview
11.5.3 Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chinese Peptide Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chinese Peptide Recent Developments
11.6 Ontores
11.6.1 Ontores Corporation Information
11.6.2 Ontores Overview
11.6.3 Ontores Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ontores Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ontores Recent Developments
11.7 GenScript
11.7.1 GenScript Corporation Information
11.7.2 GenScript Overview
11.7.3 GenScript Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GenScript Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GenScript Recent Developments
11.8 Hycult Biotech
11.8.1 Hycult Biotech Corporation Information
11.8.2 Hycult Biotech Overview
11.8.3 Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hycult Biotech Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hycult Biotech Recent Developments
11.9 Sunsmile
11.9.1 Sunsmile Corporation Information
11.9.2 Sunsmile Overview
11.9.3 Sunsmile Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sunsmile Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sunsmile Recent Developments
11.10 Ruixing Biotechnology
11.10.1 Ruixing Biotechnology Corporation Information
11.10.2 Ruixing Biotechnology Overview
11.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ruixing Biotechnology Recent Developments
11.11 Zhongnong Yingtai Biotechnology
11.11.1 Zhongnong Yingtai Biotechnology Corporation Information
11.11.2 Zhongnong Yingtai Biotechnology Overview
11.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zhongnong Yingtai Biotechnology Recent Developments
11.12 Glam Technology
11.12.1 Glam Technology Corporation Information
11.12.2 Glam Technology Overview
11.12.3 Glam Technology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Glam Technology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Glam Technology Recent Developments
11.13 ProteLight Pharmaceutical & Biotechnology
11.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
11.13.2 ProteLight Pharmaceutical & Biotechnology Overview
11.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antimicrobial Peptides Industry Chain Analysis
12.2 Antimicrobial Peptides Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antimicrobial Peptides Production Mode & Process
12.4 Antimicrobial Peptides Sales and Marketing
12.4.1 Antimicrobial Peptides Sales Channels
12.4.2 Antimicrobial Peptides Distributors
12.5 Antimicrobial Peptides Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antimicrobial Peptides Industry Trends
13.2 Antimicrobial Peptides Market Drivers
13.3 Antimicrobial Peptides Market Challenges
13.4 Antimicrobial Peptides Market Restraints
14 Key Findings in The Global Antimicrobial Peptides Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Antimicrobial Peptides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Plant Antimicrobial Peptides
Table 3. Major Manufacturers of Microbial Antimicrobial Peptides
Table 4. Major Manufacturers of Animal Antimicrobial Peptides
Table 5. Global Antimicrobial Peptides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Antimicrobial Peptides Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antimicrobial Peptides Sales by Region (2017-2022) & (Mg)
Table 8. Global Antimicrobial Peptides Sales Market Share by Region (2017-2022)
Table 9. Global Antimicrobial Peptides Sales by Region (2023-2028) & (Mg)
Table 10. Global Antimicrobial Peptides Sales Market Share by Region (2023-2028)
Table 11. Global Antimicrobial Peptides Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Antimicrobial Peptides Revenue Market Share by Region (2017-2022)
Table 13. Global Antimicrobial Peptides Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Antimicrobial Peptides Revenue Market Share by Region (2023-2028)
Table 15. Global Antimicrobial Peptides Sales by Manufacturers (2017-2022) & (Mg)
Table 16. Global Antimicrobial Peptides Sales Share by Manufacturers (2017-2022)
Table 17. Global Antimicrobial Peptides Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Antimicrobial Peptides Revenue Share by Manufacturers (2017-2022)
Table 19. Antimicrobial Peptides Price by Manufacturers (2017-2022) &(US$/Mg)
Table 20. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2021)
Table 22. Antimicrobial Peptides Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Antimicrobial Peptides Product Offered
Table 24. Date of Manufacturers Enter into Antimicrobial Peptides Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 27. Global Antimicrobial Peptides Sales by Type (2023-2028) & (Mg)
Table 28. Global Antimicrobial Peptides Sales Share by Type (2017-2022)
Table 29. Global Antimicrobial Peptides Sales Share by Type (2023-2028)
Table 30. Global Antimicrobial Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Antimicrobial Peptides Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Antimicrobial Peptides Revenue Share by Type (2017-2022)
Table 33. Global Antimicrobial Peptides Revenue Share by Type (2023-2028)
Table 34. Antimicrobial Peptides Price by Type (2017-2022) & (US$/Mg)
Table 35. Global Antimicrobial Peptides Price Forecast by Type (2023-2028) & (US$/Mg)
Table 36. Global Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 37. Global Antimicrobial Peptides Sales by Application (2023-2028) & (Mg)
Table 38. Global Antimicrobial Peptides Sales Share by Application (2017-2022)
Table 39. Global Antimicrobial Peptides Sales Share by Application (2023-2028)
Table 40. Global Antimicrobial Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Antimicrobial Peptides Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Antimicrobial Peptides Revenue Share by Application (2017-2022)
Table 43. Global Antimicrobial Peptides Revenue Share by Application (2023-2028)
Table 44. Antimicrobial Peptides Price by Application (2017-2022) & (US$/Mg)
Table 45. Global Antimicrobial Peptides Price Forecast by Application (2023-2028) & (US$/Mg)
Table 46. North America Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 47. North America Antimicrobial Peptides Sales by Type (2023-2028) & (Mg)
Table 48. North America Antimicrobial Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Antimicrobial Peptides Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 51. North America Antimicrobial Peptides Sales by Application (2023-2028) & (Mg)
Table 52. North America Antimicrobial Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Antimicrobial Peptides Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 55. North America Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 56. North America Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 59. Europe Antimicrobial Peptides Sales by Type (2023-2028) & (Mg)
Table 60. Europe Antimicrobial Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Antimicrobial Peptides Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 63. Europe Antimicrobial Peptides Sales by Application (2023-2028) & (Mg)
Table 64. Europe Antimicrobial Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Antimicrobial Peptides Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 67. Europe Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 68. Europe Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 71. Asia Pacific Antimicrobial Peptides Sales by Type (2023-2028) & (Mg)
Table 72. Asia Pacific Antimicrobial Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Antimicrobial Peptides Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 75. Asia Pacific Antimicrobial Peptides Sales by Application (2023-2028) & (Mg)
Table 76. Asia Pacific Antimicrobial Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Antimicrobial Peptides Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Antimicrobial Peptides Sales by Region (2017-2022) & (Mg)
Table 79. Asia Pacific Antimicrobial Peptides Sales by Region (2023-2028) & (Mg)
Table 80. Asia Pacific Antimicrobial Peptides Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Antimicrobial Peptides Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 83. Latin America Antimicrobial Peptides Sales by Type (2023-2028) & (Mg)
Table 84. Latin America Antimicrobial Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Antimicrobial Peptides Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 87. Latin America Antimicrobial Peptides Sales by Application (2023-2028) & (Mg)
Table 88. Latin America Antimicrobial Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Antimicrobial Peptides Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 91. Latin America Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 92. Latin America Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 95. Middle East and Africa Antimicrobial Peptides Sales by Type (2023-2028) & (Mg)
Table 96. Middle East and Africa Antimicrobial Peptides Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Antimicrobial Peptides Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 99. Middle East and Africa Antimicrobial Peptides Sales by Application (2023-2028) & (Mg)
Table 100. Middle East and Africa Antimicrobial Peptides Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Antimicrobial Peptides Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 103. Middle East and Africa Antimicrobial Peptides Sales by Country (2023-2028) & (Mg)
Table 104. Middle East and Africa Antimicrobial Peptides Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Antimicrobial Peptides Revenue by Country (2023-2028) & (US$ Million)
Table 106. AnaSpec Corporation Information
Table 107. AnaSpec Description and Major Businesses
Table 108. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 109. AnaSpec Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. AnaSpec Recent Developments
Table 111. AMP Biotech Corporation Information
Table 112. AMP Biotech Description and Major Businesses
Table 113. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 114. AMP Biotech Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. AMP Biotech Recent Developments
Table 116. Phoenix Biotech Corporation Information
Table 117. Phoenix Biotech Description and Major Businesses
Table 118. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 119. Phoenix Biotech Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Phoenix Biotech Recent Developments
Table 121. Novabiotics Corporation Information
Table 122. Novabiotics Description and Major Businesses
Table 123. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 124. Novabiotics Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Novabiotics Recent Developments
Table 126. Chinese Peptide Corporation Information
Table 127. Chinese Peptide Description and Major Businesses
Table 128. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 129. Chinese Peptide Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Chinese Peptide Recent Developments
Table 131. Ontores Corporation Information
Table 132. Ontores Description and Major Businesses
Table 133. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 134. Ontores Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Ontores Recent Developments
Table 136. GenScript Corporation Information
Table 137. GenScript Description and Major Businesses
Table 138. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 139. GenScript Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. GenScript Recent Developments
Table 141. Hycult Biotech Corporation Information
Table 142. Hycult Biotech Description and Major Businesses
Table 143. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 144. Hycult Biotech Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Hycult Biotech Recent Developments
Table 146. Sunsmile Corporation Information
Table 147. Sunsmile Description and Major Businesses
Table 148. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 149. Sunsmile Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Sunsmile Recent Developments
Table 151. Ruixing Biotechnology Corporation Information
Table 152. Ruixing Biotechnology Description and Major Businesses
Table 153. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 154. Ruixing Biotechnology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Ruixing Biotechnology Recent Developments
Table 156. Zhongnong Yingtai Biotechnology Corporation Information
Table 157. Zhongnong Yingtai Biotechnology Description and Major Businesses
Table 158. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 159. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Zhongnong Yingtai Biotechnology Recent Developments
Table 161. Glam Technology Corporation Information
Table 162. Glam Technology Description and Major Businesses
Table 163. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 164. Glam Technology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Glam Technology Recent Developments
Table 166. ProteLight Pharmaceutical & Biotechnology Corporation Information
Table 167. ProteLight Pharmaceutical & Biotechnology Description and Major Businesses
Table 168. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 169. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. ProteLight Pharmaceutical & Biotechnology Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Antimicrobial Peptides Distributors List
Table 174. Antimicrobial Peptides Customers List
Table 175. Antimicrobial Peptides Market Trends
Table 176. Antimicrobial Peptides Market Drivers
Table 177. Antimicrobial Peptides Market Challenges
Table 178. Antimicrobial Peptides Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 3. Global Antimicrobial Peptides Market Share by Type in 2021 & 2028
Figure 3. Plant Antimicrobial Peptides Product Picture
Figure 4. Microbial Antimicrobial Peptides Product Picture
Figure 5. Animal Antimicrobial Peptides Product Picture
Figure 6. Global Antimicrobial Peptides Market Share by Application in 2021 & 2028
Figure 7. Pharmaceuticals
Figure 8. Feed Additives
Figure 9. Others
Figure 10. Antimicrobial Peptides Report Years Considered
Figure 11. Global Antimicrobial Peptides Sales 2017-2028 (Mg)
Figure 12. Global Antimicrobial Peptides Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Antimicrobial Peptides Revenue 2017-2028 (US$ Million)
Figure 14. Global Antimicrobial Peptides Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Antimicrobial Peptides Sales Market Share by Region (2017-2022)
Figure 16. Global Antimicrobial Peptides Sales Market Share by Region (2023-2028)
Figure 17. North America Antimicrobial Peptides Sales YoY (2017-2028) & (Mg)
Figure 18. North America Antimicrobial Peptides Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Antimicrobial Peptides Sales YoY (2017-2028) & (Mg)
Figure 20. Europe Antimicrobial Peptides Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Antimicrobial Peptides Sales YoY (2017-2028) & (Mg)
Figure 22. Asia-Pacific Antimicrobial Peptides Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Antimicrobial Peptides Sales YoY (2017-2028) & (Mg)
Figure 24. Latin America Antimicrobial Peptides Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Antimicrobial Peptides Sales YoY (2017-2028) & (Mg)
Figure 26. Middle East & Africa Antimicrobial Peptides Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Antimicrobial Peptides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Antimicrobial Peptides in the World: Market Share by Antimicrobial Peptides Revenue in 2021
Figure 29. Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Antimicrobial Peptides Sales Market Share by Type (2017-2028)
Figure 31. Global Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
Figure 32. Global Antimicrobial Peptides Sales Market Share by Application (2017-2028)
Figure 33. Global Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
Figure 34. North America Antimicrobial Peptides Sales Market Share by Type (2017-2028)
Figure 35. North America Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
Figure 36. North America Antimicrobial Peptides Sales Market Share by Application (2017-2028)
Figure 37. North America Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
Figure 38. North America Antimicrobial Peptides Sales Share by Country (2017-2028)
Figure 39. North America Antimicrobial Peptides Revenue Share by Country (2017-2028)
Figure 40. U.S. Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Antimicrobial Peptides Sales Market Share by Type (2017-2028)
Figure 43. Europe Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
Figure 44. Europe Antimicrobial Peptides Sales Market Share by Application (2017-2028)
Figure 45. Europe Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
Figure 46. Europe Antimicrobial Peptides Sales Share by Country (2017-2028)
Figure 47. Europe Antimicrobial Peptides Revenue Share by Country (2017-2028)
Figure 48. Germany Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 49. France Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Antimicrobial Peptides Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Antimicrobial Peptides Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Antimicrobial Peptides Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Antimicrobial Peptides Revenue Share by Region (2017-2028)
Figure 59. China Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 62. India Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Antimicrobial Peptides Sales Market Share by Type (2017-2028)
Figure 70. Latin America Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Antimicrobial Peptides Sales Market Share by Application (2017-2028)
Figure 72. Latin America Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Antimicrobial Peptides Sales Share by Country (2017-2028)
Figure 74. Latin America Antimicrobial Peptides Revenue Share by Country (2017-2028)
Figure 75. Mexico Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Antimicrobial Peptides Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Antimicrobial Peptides Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Antimicrobial Peptides Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Antimicrobial Peptides Revenue Share by Country (2017-2028)
Figure 84. Turkey Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Antimicrobial Peptides Revenue (2017-2028) & (US$ Million)
Figure 87. Antimicrobial Peptides Value Chain
Figure 88. Antimicrobial Peptides Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.